Montréal Invivo
  • Business Directory
  • Newsletters
  • Events
  • News
  • FR
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • Home
  • Business Directory
  • Newsletters
  • Events
  • News
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • FRANçAIS
Back to documents
Data sheets

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

22 Feb 2024

Presentation of our Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies.

 

Produced by Synergyx Conseils Inc.

This study was carried out with financial support from Takeda, Pfizer and Vertex.

Consult the document
. - 1,53 MB
Documents

We suggest

27 Feb 2020
Briefs and consultations

Recommandations sur l’optimisation des processus d’accès aux données de santé en vue du budget provincial 2020-2021

Pour faire partie de l’économie de demain basée sur la valorisation des données massives, il faut regrouper, partager, jumeler et croiser les données et développer l’ex...

10 Sep 2025
Studies and analysis

Cartographie du financement non dilutif disponible au Québec pour les compagnies en SVTS

Veuillez noter que nos cartographies sont mises à jour chaque mois. La dernière mise à jour date du 30 septembre 2025. Pour toute suggestion de modification, écrire à agour...

16 Jun 2023
Contractor tools

Lancement du programme OTN en SVTS

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters

I want to subscribe
Montréal Invivo
  • Press releases
  • Newsletters
  • Contact us
  • Privacy policy
514 987-9377
info@montreal-invivo.com
3650 rue Saint-Urbain, bureau 711, Montréal (Québec), H2X 2L5
All rights reserved 2026 Montréal Invivo Creation and Web Design PAR Design
×
facebook twitter X home map-marker map refresh clock chevron-left chevron-up chevron-right chevron-down angle-left angl-right angle-up angle-down angle-left angle-right angle-up angle-down fax phone book search envelope-o lock print play book calendar user share2 linkedin cloud-download youtube-play spinner calendar doc pdf svg